Screening mammography can improve triple-negative breast cancer survival rates for African-American women.
The two screening methods have similar sensitivity and specificity in finding microcalcifications.
Despite recommendations, shared decision-making for lung cancer screening in practice may be far from what is intended by guidelines.
A total of 35 percent of cancers diagnosed after second-opinion review were not initially detected in the original interpretation.
The Bach model, PLCOM2012, LCRAT, and LCDRAT most accurately predict risk and performed best in selecting ever-smokers for screening.
The drop in screening mammography after 2009 coincides with publication of the USPSTF screening guidelines.
False positives from stereotactic vacuum-assisted breast biopsies do not appear to dissuade women from continuing with regular screening afterward.
Targeted dose CT lung cancer screening does not have substantial effect on life-years saved among high risk groups.
Compared to standard biopsy strategy, MR imaging-guided strategies are cost effective in helping detect prostate cancer.
Routine thyroid cancer screening among asymptomatic patients does not offer any benefit for patients.